Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Guideline-directed Medical Therapy is the Most Effective Decongestion
Author(s): Jelena Celutkiene , Alexandre Mebazaa , Jan Biegus , et al Added: 9 months ago

Heart Failure
FDA Approves Finerenone for Heart Failure with LVEF ≥40%
Added: 2 months ago Source:  Radcliffe Cardiology
The US Food and Drug Administration (FDA) has approved the non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) finerenone (Kerendia, Bayer). The new indication is for adult patients with heart failure (HF) and a left ventricular ejection fraction (LVEF) of ≥40% to reduce the risk of cardiovascular death, hospitalisation for heart failure, and urgent heart failure visits.¹ The… View more

Cardiovascular Renal Metabolic

Guidelines & Statements
Pharmacological Therapy of HFrEF in 2025
Author(s): Massimo Mapelli , Filippo Maria Rubbo , Simona Costantino , et al Added: 3 months ago

Heart Failure
Jozine ter Maaten
Research Area(s) / Expertise:

Heart Failure

 Job title: Cardiologist
Dr Jozine ter Maaten is a cardiologist at the University Medical Center Groningen, specializing in acute heart failure. Her research focuses on understanding congestion and improving diuretic response and outcomes in patients with this condition. Dr ter Maaten completed her PhD on 'Diuretic response and renal biomarkers in heart failure' in 2016 and has since been actively involved in research… View more
ESC 23: The PUSH-AHF Study
Author(s): Jozine ter Maaten Added: 2 years ago
ESC 2023 — Dr Jozine Ter Maaten (University Medical Centre Groningen, NL) joins us to outline the findings from the PUSH-AHF Study (NCT04606927). PUSH-AHF (University Medical Center Groningen) aimed to assess the effect of natriuresis-guided therapy in patients with acute heart failure to improve diagnostic response, decongestion and clinical outcomes. 310 patients with a primary diagnosis of… View more

Heart Failure
Device-Based Strategies for Guideline-Directed Therapy in Heart Failure
Author(s): Renzo Laborante , Attilio Restivo , Daniela Mele , et al Added: 6 months ago

Heart Failure

Prevention & Chronic Conditions
Simple Risk Stratification Could Optimise Heart Failure Follow-Up and Outcomes
Added: 2 months ago Source:  Radcliffe Cardiology
A new nationwide cohort study from France suggests that a simple risk stratification tool based on administrative data could help tailor cardiologist follow-up for patients with heart failure (HF), potentially improving survival and optimising resource use. The study found that 40% of patients with HF do not have an annual cardiology consultation, regardless of their disease severity.¹The French… View more

Digital Health

Guidelines & Statements
THT 2025: The FASTR Trial
Author(s): James Udelson Added: 8 months ago
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the… View more

Heart Failure
‘Residual Congestion’ in HF
Author(s): Aleksandra Gasecka , Aleksander Siniarski Added: 7 months ago

Heart Failure

Imaging & Diagnostics
HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie
Author(s): Harriette Van Spall , Mark Petrie Added: 1 year ago
HFA 2024 — Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Mark Petrie (University of Glasgow, UK) for an insightful wrap up of the novel data presented at 2024's Heart Failure Congress.00:24 - STEP HFpEF Programme: Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF & Semaglutide therapy and diuretic use in obesity-related HFpEF02:20 - EMPACT-MI: The effect of… View more

Demographic

Heart Failure